Advanced Oncotherapy (LON: AVO), recently announcedits largest single fund raise as this incredible six-year journey nears the end of the product development stage. AVO was a shell with a technology development agreement from Cern in Geneva. (Makers of the largest and fastest particle accelerator, the hydron collider). AVO’s seized its opportunity to collaborate with Cern’s 10,000 scientists to develop a new system to deliver proton beam therapy, which is a prohibitively expensive, but established effective cancer treatment.
AVO’s new ‘Linear’, LIGHT (Linac for Image Guided Hadron T...
